Allarity Therapeutics (ALLR) Short Interest Ratio & Short Volume $1.13 +0.06 (+5.61%) Closing price 04:00 PM EasternExtended Trading$1.14 +0.01 (+0.53%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Allarity Therapeutics Short Interest DataAllarity Therapeutics (ALLR) has a short interest of 1.20 million shares, representing 9.23% of the float (the number of shares available for trading by the public). This marks a 150.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 1.06 million shares to cover all short positions.Current Short Interest1,200,000 sharesPrevious Short Interest478,600 sharesChange Vs. Previous Month+150.73%Dollar Volume Sold Short$1.13 millionShort Interest Ratio0.4 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares17,015,000 sharesFloat Size13,000,000 sharesShort Percent of Float9.23%Today's Trading Volume1,705,236 sharesAverage Trading Volume1,062,886 sharesToday's Volume Vs. Average160% Short Selling Allarity Therapeutics? Sign up to receive the latest short interest report for Allarity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALLR Short Interest Over TimeALLR Days to Cover Over TimeALLR Percentage of Float Shorted Over Time Allarity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20251,200,000 shares $1.13 million +150.7%9.2%0.4 $0.94 3/15/2025478,600 shares $458,785.96 -27.1%14.1%0.2 $0.96 2/28/2025656,500 shares $524,346.55 +3.3%19.4%0.3 $0.80 2/15/2025635,600 shares $621,680.36 +30.0%18.8%0.3 $0.98 1/31/2025489,100 shares $547,792.00 -10.6%14.4%0.3 $1.12 1/15/2025547,000 shares $541,639.40 +102.8%13.8%0.4 $0.99 12/31/2024269,700 shares $315,549.00 -29.7%6.8%0.3 $1.17 12/15/2024383,700 shares $391,374.00 +50.0%9.7%0.9 $1.02 11/30/2024255,800 shares $281,380.00 +51.5%8.7%0.4 $1.10 11/15/2024168,800 shares $222,816.00 -5.9%18.0%0.3 $1.32 Get the Latest News and Ratings for ALLR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024179,400 shares $251,160.00 +60.5%19.1%0.3 $1.40 10/15/2024111,800 shares $185,588.00 -21.1%11.9%0.2 $1.66 9/30/2024141,700 shares $298,987.00 +49.8%15.1%0.3 $2.11 9/15/202494,600 shares $322,586.00 +392.7%8.9%0.2 $3.41 8/31/202419,200 shares $3,484.80 -93.6%N/A0.1 $0.18 8/15/2024299,300 shares $48,636.25 -45.4%0.7%0.1 $0.16 7/31/2024547,800 shares $99,699.60 -2.9%1.3%0.1 $0.18 7/15/2024564,200 shares $112,275.80 -67.2%2.2%0.1 $0.20 6/30/20241,720,000 shares $366,188.00 +65.4%6.7%0.3 $0.21 6/15/20241,040,000 shares $473,096.00 -11.1%4.1%0.2 $0.45 5/31/20241,170,000 shares $720,720.00 +149.6%6.7%0.3 $0.62 5/15/2024468,800 shares $318,830.88 +111.9%3.0%0.1 $0.68 4/30/2024221,200 shares $280,924.00 +110.5%10.4%0.1 $1.27 4/15/2024105,100 shares $210,200.00 +317.1%25.0%0.2 $2.00 3/31/202425,200 shares $151,754.40 -95.9%9.2%0.8 $6.02 3/15/2024614,300 shares $213,162.10 -5.9%11.8%4.7 $0.35 2/29/2024652,700 shares $252,333.82 +1.9%12.5%1.5 $0.39 2/15/2024640,300 shares $260,281.95 +0.8%17.2%0.4 $0.41 1/31/2024635,000 shares $275,971.00 -6.0%N/A0.4 $0.43 1/15/2024675,700 shares $333,322.81 +0.4%N/A0.5 $0.49 12/31/2023673,000 shares $370,890.30 -72.9%N/A0.5 $0.55 12/15/20232,480,000 shares $1.31 million +1,672.7%N/A1.7 $0.53 11/30/2023139,900 shares $77,392.68 -26.3%N/A0.1 $0.55 11/15/2023189,800 shares $93,951.00 -19.2%N/A0.6 $0.50 10/31/2023234,800 shares $130,783.60 -18.5%N/A0.8 $0.56 10/15/2023288,200 shares $208,483.88 +8.9%N/A0.5 $0.72 9/30/2023264,600 shares $197,656.20 -2.9%N/A0.4 $0.75 9/15/2023272,600 shares $258,970.00 +994.8%N/A0.3 $0.95 8/31/202324,900 shares $46,065.00 -15.6%N/A0 $1.85 8/15/202329,500 shares $57,230.00 +118.5%N/A0 $1.94Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/31/202313,500 shares $34,290.00 -78.6%N/A0 $2.54 7/15/202363,000 shares $190,260.00 +176.3%N/A0.2 $3.02 6/30/202322,800 shares $150,480.00 -87.8%N/A0.1 $6.60 6/15/2023186,300 shares $35,601.93 -33.6%N/A0.1 $0.19 5/31/2023280,600 shares $73,938.10 -40.4%N/A0.1 $0.26 5/15/2023470,800 shares $180,316.40 +180.4%N/A0.2 $0.38 4/30/2023167,900 shares $73,876.00 +21.1%N/A0.1 $0.44 4/15/2023138,700 shares $199,728.00 +134.7%N/A0.1 $1.44 3/31/202359,100 shares $99,288.00 -70.0%N/A0.3 $1.68 3/15/2023196,700 shares $894,985.00 -71.6%1.5%0 $4.55 2/28/2023691,700 shares $127,964.50 +23.8%7.5%0.3 $0.19 2/15/2023558,800 shares $105,054.40 -38.7%6.1%0.2 $0.19 1/31/2023911,800 shares $227,950.00 +320.4%9.9%0.4 $0.25 1/15/2023216,900 shares $52,923.60 +38.9%2.4%0.1 $0.24 12/30/2022156,200 shares $45,891.56 +39.2%1.7%0.2 $0.29 12/15/2022112,200 shares $29,733.00 +2,852.6%1.3%0.2 $0.27 11/30/20223,800 shares $1,706.20 -56.3%0.1%0 $0.45 11/15/20228,700 shares $4,352.61 -46.0%0.1%0.1 $0.50 10/31/202216,100 shares $9,017.61 -13.9%0.2%0.1 $0.56 10/15/202218,700 shares $15,427.50 +167.1%0.3%0.1 $0.83 9/30/20227,000 shares $7,700.00 -94.0%0.1%0 $1.10 9/15/2022117,400 shares $147,924.00 +161.5%1.6%0.4 $1.26 8/31/202244,900 shares $52,533.00 +77.5%0.6%0.2 $1.17 8/15/202225,300 shares $28,083.00 -57.4%0.3%0.1 $1.11 7/31/202259,400 shares $71,280.00 +324.3%0.8%0.4 $1.20 7/15/202214,000 shares $16,520.00 No Change0.2%0.1 $1.18 ALLR Short Interest - Frequently Asked Questions What is Allarity Therapeutics' current short interest? Short interest is the volume of Allarity Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 1,200,000 shares of ALLR short. 9.23% of Allarity Therapeutics' shares are currently sold short. Learn More on Allarity Therapeutics' current short interest. What is a good short interest percentage for Allarity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.23% of Allarity Therapeutics' floating shares are currently sold short. Is Allarity Therapeutics' short interest increasing or decreasing? Allarity Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,200,000 shares, an increase of 150.7% from the previous total of 478,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Allarity Therapeutics' float size? Allarity Therapeutics currently has issued a total of 17,015,000 shares. Some of Allarity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Allarity Therapeutics currently has a public float of 13,000,000 shares. How does Allarity Therapeutics' short interest compare to its competitors? 9.23% of Allarity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Allarity Therapeutics: Sol-Gel Technologies Ltd. (0.14%), ABVC BioPharma, Inc. (2.56%), TherapeuticsMD, Inc. (1.49%), Marker Therapeutics, Inc. (5.35%), Incannex Healthcare Inc. (0.33%), Moleculin Biotech, Inc. (4.08%), Rallybio Co. (1.69%), Minerva Neurosciences, Inc. (0.58%), Hoth Therapeutics, Inc. (2.10%), Traws Pharma, Inc. (2.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Allarity Therapeutics stock? Short selling ALLR is an investing strategy that aims to generate trading profit from Allarity Therapeutics as its price is falling. ALLR shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allarity Therapeutics? A short squeeze for Allarity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLR, which in turn drives the price of the stock up even further. How often is Allarity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLR, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies I-Mab Short Interest Invivyd Short Interest Jasper Therapeutics Short Interest Pyxis Oncology Short Interest Seres Therapeutics Short Interest Biomea Fusion Short Interest Acumen Pharmaceuticals Short Interest Renovaro Short Interest Inozyme Pharma Short Interest vTv Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALLR) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.